Cargando…

The Role of Macrophages in Nonischemic Heart Failure

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Chen, Bijun, Frangogiannis, Nikolaos G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060201/ https://www.ncbi.nlm.nih.gov/pubmed/30062210 http://dx.doi.org/10.1016/j.jacbts.2018.03.001

Ejemplares similares

Tissue transglutaminase in the pathogenesis of heart failure
por: Shinde, Arti V., et al.
Publicado: (2017)

Stratification of the Risk of Sudden Death in Nonischemic Heart Failure
por: Pimentel, Maurício, et al.
Publicado: (2014)

No Evidence of Myocardial Oxygen Deprivation in Nonischemic Heart Failure
por: Dass, Sairia, et al.
Publicado: (2015)

Identification of macrophages in normal and injured mouse tissues using reporter lines and antibodies
por: Chen, Bijun, et al.
Publicado: (2022)

Stem Cell Therapy in Patients with Chronic Nonischemic Heart Failure
por: Poglajen, Gregor, et al.
Publicado: (2018)

Ceruloplasmin and the Extent of Heart Failure in Ischemic and Nonischemic Cardiomyopathy Patients
por: Xu, Yifei, et al.
Publicado: (2013)

Oxidative Stress Status Increase in Patients with Nonischemic Heart Failure
por: Karabacak, Mustafa, et al.
Publicado: (2014)

Role of ischemia-modified albumin in patients with acute decompensated heart failure
por: Pan, Defeng, et al.
Publicado: (2016)

Mechanistic Efficacy of Sacubitril/Valsartan in Ischemic Versus Nonischemic Heart Failure
por: Mohebi, Reza, et al.
Publicado: (2023)

Follistatin-Like 1: Growing Evidence for Its Beneficial Role in Heart Failure
por: Wollert, Kai C.
Publicado: (2016)

Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure
por: Hanna, Anis, et al.
Publicado: (2020)

Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?
por: Mann, Douglas L., et al.
Publicado: (2017)

Sex Differences in Prognosis of Heart Failure Due to Ischemic and Nonischemic Cardiomyopathy
por: Mansur, Antonio de Padua, et al.
Publicado: (2023)

Heart rate in heart failure with mid-range ejection fraction
por: Yılmaz, Mehmet Birhan
Publicado: (2019)

A Growth Tonic for Heart Failure?
por: Bishopric, Nanette H.
Publicado: (2016)

Reconsidering Renal Sympathetic Denervation for Heart Failure
por: Tang, W.H. Wilson, et al.
Publicado: (2017)

Brain-derived neurotrophic factor in heart failure
por: Yılmaz, Mehmet Birhan
Publicado: (2019)

Oxytocin: A New Therapeutic for Heart Failure?
por: Habecker, Beth A.
Publicado: (2020)

Aging, cardiac repair and Smad3
por: Chen, Bijun, et al.
Publicado: (2018)

Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016)

Metabolic Coupling as a Therapeutic Strategy for Heart Failure
por: Young, Martin E.
Publicado: (2019)

Silent cerebral infarction in chronic heart failure: Ischemic and nonischemic dilated cardiomyopathy
por: Kozdag, Guliz, et al.
Publicado: (2008)

Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart Failure
por: Nishihara, Taiki, et al.
Publicado: (2021)

Ventricular arrhythmias in nonischemic cardiomyopathy: Overview
por: Kusano, Kengo
Publicado: (2018)

Abnormal heart rate recovery in patients with heart failure: an important target for exercise training treatment
por: Dimopoulos, Stavros
Publicado: (2015)

Beyond lipid lowering: pleiotropic effects of statins in heart failure
por: Swenne, C. A.
Publicado: (2013)

Cardiometabolic Heart Failure and HFpEF: Still Chasing Unicorns
por: Sharp, Thomas E., et al.
Publicado: (2019)

Targeting Mitochondrial Function in Heart Failure: Makes Sense But Will it Work?
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2019)

Modulation of Glucagon Signaling: A Metabolic Approach for Heart Failure?
por: Pocai, Alessandro
Publicado: (2019)

Promoting Health Equity in Heart Failure Amid a Pandemic
por: DeFilippis, Ersilia M., et al.
Publicado: (2021)

Innovation in Diuretic Therapy: The Missing Ingredient for Treating Worsening Heart Failure Outside the Hospital?
por: Greene, Stephen J., et al.
Publicado: (2018)

The Many Faces of NLRs in Macrophage Biology
por: Frangogiannis, Nikolaos G.
Publicado: (2023)

Unraveling the Mechanisms by Which Calpain Inhibition Prevents Heart Failure Development
por: Wehrens, Xander H.T.
Publicado: (2018)

Does nitric oxide mediate the effects of ivabradine in patients with heart failure?
por: Mączewski, Michał
Publicado: (2018)

Fine Tuning Adenylyl Cyclase as a (Gene) Therapy for Heart Failure
por: Port, J. David, et al.
Publicado: (2016)

Heart failure guidelines implementation: Lifting barriers using registries and networks
por: Keramida, Kalliopi, et al.
Publicado: (2020)

Understanding Heart Failure With Preserved Ejection Fraction in a Diabetic Way
por: Li, Haobo, et al.
Publicado: (2021)

Depression is the strongest predictor of long-term outcome in patients with chronic nonischemic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Regenerative Therapy Prevents Heart Failure Progression in Dyssynchronous Nonischemic Narrow QRS Cardiomyopathy
por: Yamada, Satsuki, et al.
Publicado: (2015)

Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure
por: Nevers, Tania, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_82v4uiqvo415ivi4jovk4jjug0